HLA-DRA and COVID-19: Significantly heightened expression of MCEMP1 and downregulation of HLA-DRA expression were detectable 4 days before the nadir of respiratory function in patients who subsequently developed severe COVID-19 (Fig. 2j), supporting that differential expression of MCEMP1 and HLA-DRA is associated with severe disease outcome.